Management of End-stage Liver Disease | Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of Drug Drug Interactions | David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Inhibition of HIV Integrase: Virology and Resistance | Charles Boucher, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Clinically Relevant Drug Interactions | Saye Khoo

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Integrase Inhibitors: Clinical Considerations | Jonathan Schapiro, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Epidemiology of Hepatitis B in Central and Eastern Europe | Adrian Streinu Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

HCV - The Virus - Geoffrey Dusheiko, MD, MB, BCh

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Acute Hepatitis C - Christoph Boesecke, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Non Hepatic Complications - Kenneth Sherman, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Chronic HepatitiRockstrohs and HIV: Implications For Care - Jürgen Rockstroh, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Treatment of HCV in HIV - Mark Sulkowski, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

ESLD a Guide for HIV Physicians - Marion Peters, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

What's new in HCV/HIV coinfection therapy - Mark Sulkowski, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Will DAA drug-drug interactions matter in the future - David Back, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Viral hepatitis and pregnancy - Eleni Nastouli

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Cost per cure-is it worth it? - Douglas Dieterich, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Towards more affordable HCV therapy - Andrew Hill, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of HCV: Pre and Post transplant - Kosh Agarwal, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

ESLD and its complications - Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015